American Injectables Rolls Out Bold Rebrand
"We wanted the brand to match what American Injectables has always stood for — highly-specialized, transparent partnership," says CEO,
"This industry is gearing up for a big shift," he continues, "Where many pharmaceutical customers have had to settle for unexplained delays and unreasonable charges, we're saying that's not 'just business.' There's a better way."
As part of the rebranding effort, team members interviewed dozens of industry professionals. Across the board, frustration with convoluted communication helped inspire American Injectables' simple, straightforward design. As a US-based company, their new look also features signature red, white, and blue—with a modern twist.
"Our mission is to bring quality injectable manufacturing back to America, improving reliable access for patients," says Garrett, "and now our brand reflects that."
In an industry often shrouded in complexity, American Injectables aims to cut through the clutter. Designed to reflect their commitment to openness, the rebrand is more than a facelift. By simplifying their messaging and visuals, they aim to make it easier for customers to understand who they are and what they stand for.
About American Injectables
American Injectables is a privately held contract development and manufacturing organization (CDMO). They specialize in flexible, end-to-end partnerships — from formulation to patient-ready vials, syringes, and cartridges. Based in
Media Contact
Senior Vice President of Business Development
[email protected]
949-291-5102
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-injectables-rolls-out-bold-rebrand-302198718.html
SOURCE American Injectables Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Streamside RV Resorts & Campgrounds Announces Acquisition of Sandy Pines Campground, Expanding Northeast Portfolio
- Polar Power Reports $7.9 Million in Pacific Islands Revenue as Repeat Orders Drive Expansion Across Off-Grid and Bad-Grid Power Markets
- Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share